The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial

References

• Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115(3):485–491.
   PubMed Web of Science ®Google Scholar
• Teh WT, Teede HJ, Paul E, et al. Risk factors for gestational diabetes mellitus: implications for the application of screening guidelines. Aust N Z J Obstet Gynaecol. 2011;51(1):26–30.
   PubMed Web of Science ®Google Scholar
• Ryan EA. Diagnosing gestational diabetes. Diabetologia. 2011;54(3):480–486.
   PubMed Web of Science ®Google Scholar
• The HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome (hapo) study: associations with neonatal anthropometrics. Diabetes. 2009;58(2):453–459.
   PubMed Web of Science ®Google Scholar
• Coustan DR, Lowe LP, Metzger BE. The hyperglycemia and adverse pregnancy outcome (HAPO) study: can we use the results as a basis for change? J Matern Fetal Neonatal Med. 2010;23(3):204–209.
   PubMed Web of Science ®Google Scholar
• Bozzetti P, Ferrari MM, Marconi AM, et al. The relationship of maternal and fetal glucose concentrations in the human from midgestation until term. Metabolism. 1988;37(4):358–363.
   PubMed Web of Science ®Google Scholar
• Phelps RL, Metzger BE, Freinkel N. Carbohydrate metabolism in pregnancy. XVII. Diurnal profiles of plasma glucose, insulin, free fatty acids, triglycerides, cholesterol, and individual amino acids in late normal pregnancy. Am J Obstet Gynecol. 1981;140(7):730–736.
   PubMed Web of Science ®Google Scholar
• Chiefari E, Arcidiacono B, Foti D, et al. Gestational diabetes mellitus: an updated overview. J Endocrinol Invest. 2017;40(9):899–909.
   PubMed Web of Science ®Google Scholar
• Larner J, Brautigan DL, Thorner MO. d-chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med. 2010;16(11–12):543–552.
   PubMed Web of Science ®Google Scholar
• Corrado F, D’Anna R, Di Vieste G, et al. The effect of myo-inositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med. 2011;28(8):972–975.
   PubMed Web of Science ®Google Scholar
• Matarrelli B, Vitacolonna E, D’Angelo M, et al. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2013;26(10):967–972.
   PubMed Web of Science ®Google Scholar
• Pak Y, Huang LC, Lilley KJ, et al. In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues. J Biol Chem. 1992;267(24):16904–16910.
   PubMed Web of Science ®Google Scholar
• Pizzo A, Laganà AS, Barbaro L. Comparison between effects of myo-inositol and d-chiro-inositol on ovarian function and metabolic factors in women with PCOS. Gynecol Endocrinol. 2014;30(3):205–208.
   PubMed Web of Science ®Google Scholar
• Colazingari S, Treglia M, Najjar R, et al. The combined therapy myo-inositol plus d-chiro-inositol, rather than d-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Arch Gynecol Obstet. 2013;288(6):1405–1411.
   PubMed Web of Science ®Google Scholar
• Malvasi A, Casciaro F, Minervini MM, et al. Myo-inositol, d-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation. Eur Rev Med Pharmacol Sci. 2014;18(2):270–274.
   PubMed Web of Science ®Google Scholar
• Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.
   PubMed Web of Science ®Google Scholar
• Conferenza Nazionale di Consenso per Raccomandazioni ed implementazione delle nuove linee guida per lo screening e la diagnosi del diabete gestazionale (GDM). Available from: http://www.sibioc.it/materiale/Documento_Finale_Consensus_Naz_GDM_afterAM2.pdf; 2010.
   Google Scholar
• Pexsters A, Daemen A, Bottomley C, et al. New crown-rump length curve based on over 3500 pregnancies. Ultrasound Obstet Gynecol. 2010;35(6):650–655.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31:S55–SS60.
   PubMed Web of Science ®Google Scholar
• Ha V, Bonner AJ, Jadoo JK, et al. The effects of various diets on glycemic outcomes during pregnancy: a systematic review and network meta-analysis. PLOS ONE. 2017;12(8):e0182095.
   PubMed Web of Science ®Google Scholar
• Russo LM, Nobles C, Ertel KA, et al. Physical activity interventions in pregnancy and risk of gestational diabetes mellitus: a systematic review and meta-analysis. Obstet Gynecol. 2015;125(3):576–582.
   PubMed Web of Science ®Google Scholar
• Kelley K, Carroll D, Meyer A. A review of current treatment strategies for gestational diabetes mellitus. DIC;4:1–15.
   Google Scholar
• Paladini D, Rustico M, Viora E, et al. Fetal size charts for the Italiana population. Normative curves of head, abdomen and long bones. Print Dig. 2005;25:456–464.
   Google Scholar
• Rutherford SE, Phelan JP, Smith CV, et al. The four-quadrant assessment of amniotic fluid volume: an adjunct to antepartum fetal heart rate testing. Obstet Gynecol. 1987;70(3 Pt 1):353–356.
   PubMed Web of Science ®Google Scholar
• Festini F, Procopio E, Taccetti G, et al. Birth weight for gestational age centiles for Italian neonates. J Matern Fetal Neonatal Med. 2004;15(6):411–417.
   PubMedGoogle Scholar
• Committee on Fetus and Newborn, Adamkin DH. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011;127(3):575–579.
   PubMed Web of Science ®Google Scholar
• Baillargeon JP, Iuorno MJ, Apridonidze T, et al. Uncoupling between insulin and release of a d-chiro-inositol-containing inositolphosphoglycan mediator of insulin action in obese women with polycystic ovary syndrome. Metab Syndr Relat Disord. 2010;8(2):127–136.
   PubMed Web of Science ®Google Scholar
• D’Anna R, Di Benedetto V, Rizzo P, et al. Myo-inositol may prevent gestational diabetes in PCOS women. Gynecol Endocrinol. 2012;28(6):440–442.
   PubMed Web of Science ®Google Scholar
• Nestler JE, Jakubowicz DJ, Reamer P, et al. Ovulatory and metabolic effects of d-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340(17):1314–1320.
   PubMed Web of Science ®Google Scholar
• Nordio M, Proietti E. The combined therapy with myo-inositol and d-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone. Eur Rev Med Pharmacol Sci. 2012;16(5):575–581.
   PubMed Web of Science ®Google Scholar
• Unfer V, Porcaro G. Updates on the myo-inositol plus d-chiro-inositol combined therapy in polycystic ovary syndrome. Expert Rev Clin Pharmacol. 2014;7(5):623–631.
   PubMed Web of Science ®Google Scholar
• Farren M, Daly N, McKeating A, et al. The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized controlled trial. Diabetes Care. 2017;40(6):759–763.
   PubMed Web of Science ®Google Scholar
• Dell’Edera D, Sarlo F, Allegretti A, et al. The influence of d-chiro-inositol and d-myo-inositol in pregnant women with glucose intolerance. Biomed Rep. 2017;7(2):169–172.
   PubMed Web of Science ®Google Scholar
• Malvasi A, Kosmas I, Mynbaev OA, et al. Can trans resveratrol plus d-chiro-inositol and myo-inositol improve maternal metabolic profile in overweight pregnant patients? Clin Ter. 2017;168(4):e240–ee247.
   PubMed Web of Science ®Google Scholar
• D’Anna R, Scilipoti A, Giordano D, et al. Myo-inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study. Diabetes Care. 2013;36(4):854–857.
   PubMed Web of Science ®Google Scholar
• D’Anna R, Di Benedetto A, Scilipoti A, et al. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial. Obstet Gynecol. 2015;126(2):310–315.
   PubMed Web of Science ®Google Scholar
• Saltiel AR. Second messengers of insulin action. Diabetes Care. 1990;13(3):244–256.
   PubMed Web of Science ®Google Scholar
• Corrado F, D’Anna R, Cannata ML, et al. Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes Metab. 2012;38(5):458–461.
   PubMed Web of Science ®Google Scholar
• Wier LM, Witt E, Burgess J, et al. Hospitalizations related to diabetes in pregnancy, 2008. In: Statistical Brief #102. Rockville (MD): Agency for Healthcare Research and Quality (US); 2010. Available from: https://www.ncbi.nlm.gov/books/NBK52649/.
   Google Scholar
• Zhang Y, Shao J, Li F, et al. Factors in Gestational diabetes mellitus predicting the needs for insulin therapy. Int J Endocrinol. 2016;2016:4858976.
   PubMed Web of Science ®Google Scholar